IL66726A0 - Improvements in or relating to thieno and furopyridinium-substituted cephalosporin derivatives - Google Patents
Improvements in or relating to thieno and furopyridinium-substituted cephalosporin derivativesInfo
- Publication number
- IL66726A0 IL66726A0 IL66726A IL6672682A IL66726A0 IL 66726 A0 IL66726 A0 IL 66726A0 IL 66726 A IL66726 A IL 66726A IL 6672682 A IL6672682 A IL 6672682A IL 66726 A0 IL66726 A0 IL 66726A0
- Authority
- IL
- Israel
- Prior art keywords
- furopyridinium
- thieno
- relating
- cephalosporin derivatives
- substituted cephalosporin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30035781A | 1981-09-08 | 1981-09-08 | |
US34062882A | 1982-01-19 | 1982-01-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL66726A0 true IL66726A0 (en) | 1982-12-31 |
Family
ID=26971737
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL66726A IL66726A0 (en) | 1981-09-08 | 1982-09-06 | Improvements in or relating to thieno and furopyridinium-substituted cephalosporin derivatives |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0074268A3 (fr) |
KR (1) | KR840001585A (fr) |
CS (1) | CS232735B2 (fr) |
DD (1) | DD209633A5 (fr) |
DK (1) | DK399282A (fr) |
ES (2) | ES515548A0 (fr) |
FI (1) | FI823088L (fr) |
GB (1) | GB2105719A (fr) |
GR (1) | GR76701B (fr) |
HU (1) | HU187575B (fr) |
IL (1) | IL66726A0 (fr) |
NZ (1) | NZ201833A (fr) |
PH (1) | PH19756A (fr) |
PL (1) | PL238158A1 (fr) |
PT (1) | PT75518B (fr) |
RO (1) | RO84456B (fr) |
SU (1) | SU1169542A3 (fr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0097961B1 (fr) * | 1982-06-28 | 1987-11-11 | Bristol-Myers Company | Dérivés de céphalosporines, leur procédé de préparation et compositions pharmaceutiques les contenant |
US4480098A (en) * | 1982-11-12 | 1984-10-30 | Eli Lilly And Company | Preparation of alkali metal thieno(furo)pyridines |
US4525473A (en) * | 1983-03-30 | 1985-06-25 | Bristol-Myers Company | Cephalosporins |
EP0137442A3 (fr) * | 1983-10-08 | 1986-01-15 | Hoechst Aktiengesellschaft | Dérivés de céphalosporine et procédé pour leur préparation |
GB2148289B (en) * | 1983-10-17 | 1987-09-23 | Lilly Co Eli | 3-bicyclicpyridinium-methyl cephalosporins |
EP0182633A3 (fr) * | 1984-11-20 | 1987-09-02 | Ici Pharma | Dérivés de céphalosporine |
EP0187456A1 (fr) * | 1984-11-29 | 1986-07-16 | Ici Pharma | Dérivés de céphalosporine |
ATE89826T1 (de) * | 1985-03-01 | 1993-06-15 | Takeda Chemical Industries Ltd | Antibakterielle verbindungen, ihre herstellung und verwendung. |
US4703118A (en) * | 1985-04-08 | 1987-10-27 | Eli Lilly And Company | Synthesis of 3-iodomethyl cephalosporins |
US4714760A (en) * | 1985-08-20 | 1987-12-22 | Bristol-Myers Company | Cephalosporin intermediates |
GB8626245D0 (en) * | 1985-11-27 | 1986-12-03 | Ici Pharma | Cephalosporin compounds |
US4868294A (en) * | 1986-07-11 | 1989-09-19 | Bristol-Myers Company | Process for preparing cephalosporin intermediates |
US4918067A (en) * | 1986-07-24 | 1990-04-17 | Beecham Group P.L.C. | Heterocyclic substituted penicillin antibiotics |
TW526202B (en) | 1998-11-27 | 2003-04-01 | Shionogi & Amp Co | Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity |
US6642238B2 (en) | 2000-02-10 | 2003-11-04 | Pharmacia And Upjohn Company | Oxazolidinone thioamides with piperazine amide substituents |
CA2395648A1 (fr) * | 2000-02-10 | 2001-08-16 | Pharmacia & Upjohn Company | Thioamides d'oxazolidinone a substituants amides de piperazine |
US7847093B2 (en) | 2003-04-16 | 2010-12-07 | Sandoz Ag | Processes for the preparations of cefepime |
ATE473986T1 (de) | 2003-04-16 | 2010-07-15 | Sandoz Ag | Verfahren zur herstellung von cefepim |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1399086A (en) * | 1971-05-14 | 1975-06-25 | Glaxo Lab Ltd | Cephalosporin compounds |
DE2715385A1 (de) * | 1976-04-14 | 1977-11-10 | Takeda Chemical Industries Ltd | Cephalosporinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel |
DE2714880A1 (de) * | 1977-04-02 | 1978-10-26 | Hoechst Ag | Cephemderivate und verfahren zu ihrer herstellung |
FR2440738A1 (fr) * | 1978-11-13 | 1980-06-06 | Parcor | Medicament a base de derives des thieno (2,3-c) et (3,2-c) pyridines |
DE3118732A1 (de) * | 1981-05-12 | 1982-12-02 | Hoechst Ag, 6000 Frankfurt | Cephalosporinderivate und verfahren zu ihrer herstellung |
DE3207840A1 (de) * | 1982-03-04 | 1983-09-15 | Hoechst Ag, 6230 Frankfurt | "cephalosporinderivate und verfahren zu ihrer herstellung" |
-
1982
- 1982-09-06 IL IL66726A patent/IL66726A0/xx unknown
- 1982-09-06 GR GR69206A patent/GR76701B/el unknown
- 1982-09-06 SU SU823485553A patent/SU1169542A3/ru active
- 1982-09-06 RO RO108573A patent/RO84456B/ro unknown
- 1982-09-06 PL PL23815882A patent/PL238158A1/xx unknown
- 1982-09-07 KR KR1019820004043A patent/KR840001585A/ko unknown
- 1982-09-07 FI FI823088A patent/FI823088L/fi not_active Application Discontinuation
- 1982-09-07 ES ES515548A patent/ES515548A0/es active Granted
- 1982-09-07 NZ NZ201833A patent/NZ201833A/xx unknown
- 1982-09-07 EP EP82304674A patent/EP0074268A3/fr not_active Withdrawn
- 1982-09-07 PT PT75518A patent/PT75518B/pt unknown
- 1982-09-07 HU HU822856A patent/HU187575B/hu unknown
- 1982-09-07 DD DD82243071A patent/DD209633A5/de unknown
- 1982-09-07 GB GB08225403A patent/GB2105719A/en not_active Withdrawn
- 1982-09-07 DK DK399282A patent/DK399282A/da not_active Application Discontinuation
- 1982-09-07 PH PH27833A patent/PH19756A/en unknown
- 1982-09-08 CS CS826505A patent/CS232735B2/cs unknown
-
1983
- 1983-12-02 ES ES527763A patent/ES8505374A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DK399282A (da) | 1983-03-09 |
NZ201833A (en) | 1985-09-13 |
PL238158A1 (en) | 1984-11-19 |
EP0074268A2 (fr) | 1983-03-16 |
DD209633A5 (de) | 1984-05-16 |
CS650582A2 (en) | 1984-06-18 |
ES527763A0 (es) | 1985-05-16 |
ES8505374A1 (es) | 1985-05-16 |
KR840001585A (ko) | 1984-05-07 |
PT75518B (en) | 1985-11-12 |
PT75518A (en) | 1982-10-01 |
HU187575B (en) | 1986-01-28 |
PH19756A (en) | 1986-06-26 |
CS232735B2 (en) | 1985-02-14 |
GR76701B (fr) | 1984-08-29 |
SU1169542A3 (ru) | 1985-07-23 |
ES8404361A1 (es) | 1984-04-16 |
FI823088A0 (fi) | 1982-09-07 |
ES515548A0 (es) | 1984-04-16 |
GB2105719A (en) | 1983-03-30 |
RO84456A (fr) | 1984-06-21 |
FI823088L (fi) | 1983-03-09 |
RO84456B (ro) | 1984-08-30 |
EP0074268A3 (fr) | 1984-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS57192394A (en) | Cephalosporin derivatives and manufacture | |
EG15899A (en) | Improvement in or relating to n-arybenzamide derivatives | |
IL70075A0 (en) | Improvements in or relating to 3-aryl-5-pyrazole derivatives | |
GB2084573B (en) | Improvements in or relating to 3-aryl-5-isothiazole derivatives | |
IL66726A0 (en) | Improvements in or relating to thieno and furopyridinium-substituted cephalosporin derivatives | |
EP0080442A3 (en) | Di-galactose derivatives and their preparation | |
PT78985B (en) | Improvements in or relating to cephalosporins | |
GB2095497B (en) | Improvements in and relating to direction finding | |
SG59789G (en) | Improvements in or relating to cephalosporin derivatives | |
ZA826538B (en) | Thieno and furopyridinium-substituted cephalosporin derivatives | |
IL64774A (en) | Hexahydro-trans and tetrahydropyridoindole derivatives | |
AU8300083A (en) | Improvements in or relating to trailers | |
GB2137997B (en) | Improvements in or relating to indolylglycyl cephalosporin derivatives | |
GB2100303B (en) | Improvements in or relating to cardclothing | |
IL71497A0 (en) | Improvements in or relating to benzothienylglycyl cephalosporin derivatives | |
PT74879A (en) | Improvements in or relating to construction | |
IL71496A0 (en) | Improvements in or relating to benzothienylglycyl cephalosporin derivatives | |
DE3266355D1 (en) | Octahydrotetracyanoquinodimethane and derivatives thereof | |
DE3268189D1 (en) | Improvements in and relating to differential signal decoders | |
ZM1684A1 (en) | Improvements in or relating to naphthylglycyl cephalosporin derivatives | |
AR242033A1 (es) | Un procedimiento para la preparacion de un derivado de 2-amino-pirimido(4,5-g)-quinolina y lactamas de aplicacion exclusiva en dicho procedimiento. | |
GB2093505B (en) | Improvements in or relating to tunnels | |
JPS57179198A (en) | 3-oxo-17 alpha-ethynyl-17 beta-trifluoroacetoxy- gonane derivatives and manufacture | |
IL71500A0 (en) | Improvements in or relating to naphthylglycyl cephalosporin derivatives | |
IL70854A0 (en) | Improvements in or relating to benzazepine derivatives |